Johnson & Johnson has been working behind the scenes to turn around its massive $25 billion-a-year medical device business.
The efforts appear to be paying off.
After it held its annual analyst day Wednesday, many analysts now believe that the company’s device business will grow greater than the overall medtech market growth of 4–6%.
Before delving into how it will achieve the above-market growth, it’s worthwhile to understand the device business segments and how they performed last year.
